Personalised relaxation practice to improve sleep and functioning in patients with chronic fatigue syndrome and depression: study protocol for a randomised controlled trial

Trials
Claire L MacnamaraUte Vollmer-Conna

Abstract

Chronic fatigue syndrome (CFS) and major depressive disorder (MDD) are both debilitating but heterogeneous conditions sharing core features of fatigue, unrefreshing sleep, and impaired functioning. The aetiology of these conditions is not fully understood, and 'best-practice' treatments are only moderately effective in relieving symptoms. Unrecognised individual differences in the response to such treatments are likely to underlie poor treatment outcomes. We are undertaking a two-group, parallel, randomised controlled trial (RCT) comparing the effects of a personalised relaxation intervention on sleep quality, daytime symptoms, and functioning in patients with CFS (n = 64) and MDD (n = 64). Following identification of the method that best enhances autonomic responding (such as heart rate variability), participants randomised to the active intervention will practise their recommended method nightly for 4 weeks. All participants will keep a sleep diary and monitor symptoms during the trial period, and they will complete two face-to-face assessments, one at baseline and one at 4 weeks, and a further online assessment to evaluate lasting effects of the intervention at 2 months. Assessments include self-report measures of sleep, wel...Continue Reading

References

Aug 1, 1987·Pain·Ronald Melzack
May 1, 1994·American Heart Journal·P K SteinB M Conger
Jan 1, 1993·Journal of Psychosomatic Research·S LevensteinA Andreoli
Dec 22, 2000·Spine·J E Ware
Sep 5, 2001·The Australian and New Zealand Journal of Psychiatry·A WilsonA Lloyd
Aug 6, 2003·Medicine and Science in Sports and Exercise·Cora L CraigPekka Oja
Jan 20, 2004·The Journal of Clinical Psychiatry·Paul E GreenbergPatricia K Corey-Lisle
Oct 16, 2004·The International Journal of Neuropsychopharmacology·Koen DemyttenaereStephen M Stahl
Dec 22, 2006·Biological Psychology·Julian F Thayer, Richard D Lane
Mar 3, 2007·Applied Psychophysiology and Biofeedback·Maria Katsamanis KaravidasAfton Hassett
Sep 14, 2007·Autonomic Neuroscience : Basic & Clinical·Roumiana S BonevaWilliam C Reeves
Apr 10, 2008·Dynamic Medicine : DM·Leonard A JasonSusan Torres-Harding
May 9, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Julian F ThayerBjorn Helge Johnsen
Mar 31, 2010·Journal of Consulting and Clinical Psychology·Stefan G HofmannDiana Oh
Oct 13, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·David Goldberg
Mar 1, 2012·The Psychiatric Clinics of North America·Donna M Sudak
Feb 1, 2013·Psychological Medicine·P D WhiteM Sharpe
Mar 19, 2013·Autonomic Neuroscience : Basic & Clinical·Fumiharu Togo, Benjamin H Natelson
Apr 12, 2013·Clinical Epidemiology·Samantha JohnstonSonya Marshall-Gradisnik
Apr 23, 2013·Journal of Science and Medicine in Sport·Robert Stanton, Peter Reaburn
Sep 17, 2013·Annals of the New York Academy of Sciences·Yi-Yuan TangMary K Rothbart
Oct 8, 2013·Handbook of Clinical Neurology·Iwona Cygankiewicz, Wojciech Zareba
Jan 8, 2014·JAMA Internal Medicine·Madhav GoyalJennifer A Haythornthwaite
Jul 7, 2017·The Journal of Clinical Psychiatry·Roger S McIntyreMichael Ostacher

❮ Previous
Next ❯

Methods Mentioned

BETA
cognitive-behavioural therapy
contraception

Software Mentioned

LabChart
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.